Molecular genetic analysis of oligodendroglial tumors for alterations of the CDKN2A and CDKN2B tumor suppressor genes

被引：0
|
作者：
Wolter, M
Reifenberger, J
Ichimura, K
Schmidt, EE
Collins, VP
Reifenberger, G
机构：
来源：
BRAIN PATHOLOGY | 2000年 / 10卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：570 / 571
页数：2
相关论文
共 50 条
  • [21] Germline heterozygous deletion containing CDKN2A/CDKN2B as genetic substrate for rare familial neural and skin tumor syndrome
    Hannes, Laurens
    Brems, Hilde
    Clement, Paul
    De Vleeschouwer, Steven
    Garmyn, Marjan
    Sciot, Raf
    Van Calenbergh, Frank
    Legius, Eric
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2024, 32 : 583 - 583
  • [22] Promoter hypermethylation inactivates CDKN2A, CDKN2B and RASSF1A genes in sporadic parathyroid adenomas
    Ashutosh Kumar Arya
    Sanjay Kumar Bhadada
    Priyanka Singh
    Naresh Sachdeva
    Uma Nahar Saikia
    Divya Dahiya
    Arunanshu Behera
    Anil Bhansali
    Sudhaker D. Rao
    Scientific Reports, 7
  • [23] Promoter hypermethylation inactivates CDKN2A, CDKN2B and RASSF1A genes in sporadic parathyroid adenomas
    Arya, Ashutosh Kumar
    Bhadada, Sanjay Kumar
    Singh, Priyanka
    Sachdeva, Naresh
    Saikia, Uma Nahar
    Dahiya, Divya
    Behera, Arunanshu
    Bhansali, Anil
    Rao, Sudhaker D.
    SCIENTIFIC REPORTS, 2017, 7
  • [24] CDKN2A/CDKN2B as a Hotspot for Acute Lymphoblastic Leukemia Susceptibility in the Spanish Population
    Gutierrez-Camino, A.
    Martin-Guerrero, I.
    Garcia de Andoin, N.
    Navajas, A.
    Sastre, A.
    Carbone Baneres, A.
    Astigarraga, I.
    Garcia-Orad, A.
    PEDIATRIC BLOOD & CANCER, 2016, 63 : S65 - S66
  • [25] Oligodendroglial tumors frequently demonstrate hypermethylation of the CDKN2A (MTS1, p16INK4a), p14ARF, and CDKN2B (MTS2, p15INK4b) tumor suppressor genes
    Wolter, M
    Reifenberger, J
    Blaschke, B
    Ichimura, K
    Schmidt, EE
    Collins, VP
    Reifenberger, G
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2001, 60 (12): : 1170 - 1180
  • [26] PROMOTER HYPERMETHYLATION MEDIATED SUPPRESSION OF CYCLIN DEPENDENT KINASE INHIBITORS (CDKN2A AND CDKN2B) IN SPORADIC PARATHYROID TUMORS
    Arya, A.
    Singh, P.
    Bhadada, S.
    Saikia, U.
    Sachdeva, N.
    Dahiya, D.
    Behera, A.
    Bhansali, A.
    OSTEOPOROSIS INTERNATIONAL, 2016, 27 : S704 - S704
  • [27] Mutation analysis of genes that control the G1/S cell cycle in melanoma: TP53, CDKN1A, CDKN2A, and CDKN2B
    José Luis Soto
    Carmen M Cabrera
    Salvio Serrano
    Miguel Ángel López-Nevot
    BMC Cancer, 5
  • [28] CDKN2A Alterations and Response to Immunotherapy in Solid Tumors
    Adib, Elio
    Nassar, Amin H.
    Akl, Elie W.
    Abou Alaiwi, Sarah
    Nuzzo, Pier Vitale
    Mouhieddine, Tarek H.
    Sonpavde, Guru
    Haddad, Robert, I
    Mouw, Kent W.
    Giannakis, Marios
    Hodi, F. Stephen
    Shukla, Sachet A.
    Gusev, Alexander
    Braun, David A.
    Choueiri, Toni K.
    Kwiatkowski, David J.
    CLINICAL CANCER RESEARCH, 2021, 27 (14) : 4025 - 4035
  • [29] DNA methylation analysis of the tumor suppressor gene CDKN2B in Brazilian leukemia patients
    Pereira Lima, Patricia Santos
    Molffeta, Greice Andreoti
    de Araujo, Amelia Goes
    Zago, Marco Antonio
    da Silva, Wilson Araujo, Jr.
    GENETICS AND MOLECULAR BIOLOGY, 2008, 31 (03) : 632 - 638
  • [30] THE TUMOR SUPPRESSOR CDKN2A REMODELS THE LIPIDOME OF GLIOBLASTOMA
    Minami, J. K.
    Morrow, D.
    Bayley, N. A.
    Fernandez, E. G.
    Salinas, J. J.
    Tse, C.
    CANCER DISCOVERY, 2023, 13 (08) : 1760 - 1760
12345